There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rocket Pharmaceuticals Inc (RCKT) and AnaptysBio Inc (ANAB) with bullish sentiments.
Rocket Pharmaceuticals Inc (RCKT)
In a report released today, Yaron Werber from Cowen & Co. maintained a Buy rating on Rocket Pharmaceuticals Inc. The company’s shares opened today at $18.57.
According to TipRanks.com, Werber is a 4-star analyst with an average return of 13.6% and a 60.2% success rate. Werber covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Inc., Unum Therapeutics Inc, and Acceleron Pharma.
Rocket Pharmaceuticals Inc has an analyst consensus of Strong Buy, with a price target consensus of $39, which is an 110.0% upside from current levels. In a report issued on April 30, William Blair also assigned a Buy rating to the stock.
See today’s analyst top recommended stocks >>
AnaptysBio Inc (ANAB)
In a report released today, Derek Archila from Stifel Nicolaus reiterated a Buy rating on AnaptysBio Inc, with a price target of $124. The company’s shares opened today at $70.83.
Archila commented:
“Catalysts .Financial Rating — Buy Target Price — $124.00 FY18A EPS — $(2.50) Revenue — $5.0 FY19E Revenue — $0.0 Price ( 05/08/19 ): $70.23 52-Week Range: $110 – $54 1,692.5 Shr.O/S-Diluted (mm): 24.1 238,452 Dividend / Yield: $0.00 / 0.0% Cash (mm): $484 Price: Intraday 5-8-19.”
According to TipRanks.com, Archila has 0 stars on 0-5 star ranking scale with an average return of -8.8% and a 33.1% success rate. Archila covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Rhythm Pharmaceuticals Inc, and Principia Biopharma Inc.
Currently, the analyst consensus on AnaptysBio Inc is a Strong Buy with an average price target of $131.25, representing an 85.3% upside. In a report issued on May 3, Cantor Fitzgerald also maintained a Buy rating on the stock with a $140 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
